Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 54026 - 54050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Oxaliplatin	Approved Investigational	DDB1	1642	upregulated	oxaliplatin results in increased expression of DDB1 mRNA	11q12.2	A23409
Oxaliplatin	Approved Investigational	DUT	1854	downregulated	oxaliplatin results in decreased expression of DUT mRNA	15q21.1	A23413
Oxaliplatin	Approved Investigational	DVL3	1857	upregulated	oxaliplatin results in increased expression of DVL3 mRNA	3q27.1	A23409
Oxaliplatin	Approved Investigational	EPN3	55040	upregulated	oxaliplatin results in increased expression of EPN3 mRNA	17q21.33	A22638
Oxaliplatin	Approved Investigational	ERCC1	2067	upregulated	oxaliplatin results in increased expression of ERCC1 mRNA	19q13.32	A23410
Oxaliplatin	Approved Investigational	ERCC2	2068	upregulated	oxaliplatin results in increased expression of ERCC2 mRNA	19q13.32	A23410
Oxaliplatin	Approved Investigational	ETFA	2108	downregulated	oxaliplatin results in decreased expression of ETFA mRNA	15q24.2-q24.3	A23409
Oxaliplatin	Approved Investigational	F3	2152	downregulated	oxaliplatin results in decreased expression of F3 mRNA	1p21.3	A22638
Oxaliplatin	Approved Investigational	FAM198B	51313	upregulated	oxaliplatin results in increased expression of FAM198B mRNA	4q32.1	A22638
Oxaliplatin	Approved Investigational	FGFR2	2263	upregulated	oxaliplatin results in increased expression of FGFR2 mRNA	10q26.13	A23409
Oxaliplatin	Approved Investigational	FHL1	2273	downregulated	oxaliplatin results in decreased expression of FHL1 mRNA	Xq26.3	A23409
Oxaliplatin	Approved Investigational	FXYD3	5349	upregulated	oxaliplatin results in increased expression of FXYD3 mRNA	19q13.12	A22640
Oxaliplatin	Approved Investigational	GRK7	131890	downregulated	oxaliplatin results in decreased expression of GRK7 mRNA	3q23	A23409
Oxaliplatin	Approved Investigational	GSTP1	2950	upregulated	oxaliplatin results in increased expression of GSTP1 mRNA	11q13.2	A23410
Oxaliplatin	Approved Investigational	HDGF	3068	downregulated	oxaliplatin results in decreased expression of HDGF mRNA	1q23.1	A23409
Oxaliplatin	Approved Investigational	HEY1	23462	downregulated	oxaliplatin results in decreased expression of HEY1 mRNA	8q21.13	A23409
Oxaliplatin	Approved Investigational	HSPE1	3336	upregulated	oxaliplatin results in increased expression of HSPE1 mRNA	2q33.1	A22640
Oxaliplatin	Approved Investigational	IGFBP3	3486	downregulated	oxaliplatin results in decreased expression of IGFBP3 mRNA	7p12.3	A23409
Oxaliplatin	Approved Investigational	INSIG1	3638	downregulated	oxaliplatin results in decreased expression of INSIG1 mRNA	7q36.3	A22638
Oxaliplatin	Approved Investigational	ITGB8	3696	downregulated	oxaliplatin results in decreased expression of ITGB8 mRNA	7p21.1	A22638
Oxaliplatin	Approved Investigational	KCNK15	60598	downregulated	oxaliplatin results in decreased expression of KCNK15 mRNA	20q13.12	A23409
Oxaliplatin	Approved Investigational	MAN1A1	4121	upregulated	oxaliplatin results in increased expression of MAN1A1 mRNA	6q22.31	A22638
Oxaliplatin	Approved Investigational	MAP2	4133	upregulated	oxaliplatin results in increased expression of MAP2 mRNA	2q34	A22638
Oxaliplatin	Approved Investigational	MAP3K20	51776	downregulated	oxaliplatin results in decreased expression of MAP3K20 mRNA	2q31.1	A22638
Oxaliplatin	Approved Investigational	MARCKS	4082	upregulated	oxaliplatin results in increased expression of MARCKS mRNA	6q21	A23409

Displaying entries 54026 - 54050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability